Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global hemostasis products market 360° synopsis, 2018 – 2032
2.2 Regional trends
2.3 Product trends
2.4 Application trends
2.5 End-use trends
Chapter 3 Hemostasis Products Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 The rising prevalence of cardiac disorders worldwide
3.5.1.2 The growing incidence of accidents and trauma cases across the globe
3.5.1.3 Technological advancements in hemostasis products
3.5.2 Industry pitfalls & challenges
3.5.2.1 High expense needed for hemostasis products due to the usage of advanced technology for hemostat
3.5.2.2 Lack of skilled professionals for carrying out surgical procedures
3.6 Growth potential analysis
3.6.1 By product
3.6.2 By application
3.6.3 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Medtronic Plc
4.1.2 Johnson & Johnson Services Inc
4.1.3 Baxter International Inc
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Hemostasis Products Market Estimates and Forecast, By Product (Revenue)
5.1 Key trends, by product
5.2 Topical hemostasis products
5.2.1 Gelatin
5.2.2 Polysaccharides
5.2.3 Oxidized regenerated cellulose
5.2.4 Collagen
5.3 Infusible hemostasis products
5.3.1 Fresh frozen plasma (FFP)
5.3.2 Factor VIII
5.3.3 Platelet concentrate from donor blood
5.3.4 Prothrombin
5.4 Advanced hemostasis products
5.4.1 Flowable
5.4.2 Thrombin
5.4.3 Synthetic sealant
5.4.4 Fibrin
Chapter 6 Hemostasis Products Market Estimates and Forecast, By Application (Revenue)
6.1 Key trends, by application
6.2 Trauma
6.3 Surgery
6.4 Hemophilia
6.5 Myocardial infarction
6.6 Others
Chapter 7 Hemostasis Products Market Estimates and Forecast, By End-use (Revenue)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Others
Chapter 8 Hemostasis Products Market Estimates and Forecast, By Region (Revenue)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Switerland
8.3.7 The Netherlands
8.3.8 Denmark
8.3.9 Poland
8.3.10 Sweden
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 New Zealand
8.4.7 Thailand
8.4.8 Vietnam
8.4.9 Indonesia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Turkey
Chapter 9 Company Profiles
9.1 Medtronic Plc
9.2 Johnson & Johnson Services Inc
9.3 Baxter International Inc
9.4 Pfizer, Inc
9.5 Becton, Dickinson and Company (BD)
9.6 B. Braun Melsungen AG
9.7 Tricol Biomedical
9.8 Hemostasis LLC
9.9 Teleflex Incorporated
9.10 CuraMedical BV
